Can-Fite BioPharma Ltd. EFFECT, filed Mar 30, 2022: primary_doc.xml
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 30, 2022 |
| Accession Number: | 0001213900-22-015189 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||